| Revenue growth | 23.1% YoY growth driven by volume and premium test mix shift. |
|---|---|
| Margins | Blended margins dipped to 31.8% due to new center drag. |
| Demand visibility | Strong demand in Eastern India; expansion into Bihar, Jharkhand, and Tripura. |
| Management confidence | High confidence in regional expansion and technology-led service enhancements. |
Growth
Topline grew 23% to ₹3,104M; FY23-FY26 revenue CAGR stands at a strong 17.8% with improving patient yields.
Outlook
Guided 15% revenue growth for FY27; aiming for 100 centers by FY28 with 14 new openings planned.
Risks
EBITDA margins compressed by 200bps YoY to 31.8% due to high pre-operative costs of new centers.
Earnings Call filed with BSE, NSE: SURAKSHA. Summary written with AI assistance from the document.
Suraksha Diagnostic Ltd: key numbers
- Share price
- ₹324.10
- Market cap
- ₹1,688 Cr
- Revenue (annual)
- ₹310.4 Cr
- Net profit (annual)
- ₹32.19 Cr
- P/E (TTM)
- 47.1×Sector 53.1×
- Promoter holding
- 49.10%+0.00% QoQ
- FII holding
- 13.47%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Suraksha Diagnostic Ltd
All →Suraksha Diagnostic Annual General Meeting
Suraksha Diagnostic Ltd held its 21st AGM on September 22, 2026. Members adopted financial statements, approved a final dividend, and ratified cost auditor remuneration.
Suraksha Diagnostic Annual General Meeting
Suraksha Diagnostic Limited has issued a notice for its 21st Annual General Meeting scheduled for September 22, 2026, to conduct routine business and dividend declaration.
- Value
- ₹0.01 Cr
Suraksha Diagnostic Annual General Meeting
Suraksha Diagnostic Limited has issued a notice for its 21st Annual General Meeting to be held on September 22, 2026, to transact key corporate business.
Suraksha Diagnostic Other Announcement
Suraksha Diagnostic informed exchanges about dispatching letters to shareholders with unregistered emails, providing web links to access the 21st AGM notice and Annual Report.
Suraksha Diagnostic Annual Report
Suraksha Diagnostic Limited has filed its Annual Report for FY 2025-26, including the notice for the 21st Annual General Meeting scheduled for September 22, 2026.
Suraksha Diagnostic Earnings Call Transcript: Key Takeaways
Suraksha Diagnostic reported a robust Q1 FY27 with 21% revenue growth and 40% PAT growth, driven by expansion in West Bengal and Jharkhand and a high-growth genomics segment.
- Call
- Guides 15% growth